EI
CRL icon

EAM Investors’s Charles River Laboratories CRL Stock Holding History

EAM Investors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,417
Closed -$1.23M – 313
2020
Q3 		$1.23M Sell
5,417
-2,084
-28% -$432K 0.29% 157
2020
Q2 		$1.31M Sell
7,501
-4,545
-38% -$725K 0.29% 165
2020
Q1 		$1.52M Buy
+12,046
New +$1.81M 0.47% 100
2014
Q3 		– Sell
-23,770
Closed -$1.27M – 327
2014
Q2 		$1.27M Buy
23,770
+1,424
+6% +$78.1K 0.24% 221
2014
Q1 		$1.35M Buy
+22,346
New +$1.3M 0.24% 198

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

EAM Investors's CRL Position: Q4 2020 in Review

EAM Investors sold out of Charles River Laboratories (CRL) in Q4 2020, closing a stake of 5,417 shares — an estimated $1.23M sold.

EAM Investors first reported a position in CRL in Q1 2014 and held it in 5 quarters. The position peaked at $1.52M in Q1 2020. 539 funds tracked by Wall St. Rank hold CRL as of Q4 2020.

  • EAM Investors reported no remaining Charles River Laboratories position as of Q4 2020 after selling out during the quarter.
  • EAM Investors sold 5,417 Charles River Laboratories shares in Q4 2020, an estimated $1.23M.
  • EAM Investors first reported a position in Charles River Laboratories in Q1 2014 and held it in 5 quarters.
  • EAM Investors's Charles River Laboratories position peaked at $1.52M in Q1 2020.
  • 539 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2020.

Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.